Steward Partners Investment Advisory, LLC Novo Nordisk A S Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 181,470 shares of NVO stock, worth $15.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

181,470

Previous 189,458 4.22%

Holding current value

$15.4 Million

Previous $27 Million 20.1%

% of portfolio

0.2%

Previous 0.29%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $951,131 - $1.16 Million	-7,988 Reduced 4.22%	181,470 $21.6 Million
Q2 2024 Aug 08, 2024	BUY	$122.71 - $146.91 $938,976 - $1.12 Million	7,652 Added 4.21%	189,458 $27 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $2.7 Million - $3.59 Million	26,409 Added 16.99%	181,806 $23.3 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $1.65 Million - $1.99 Million	18,842 Added 13.8%	155,397 $16.1 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $7.17 Million - $15.7 Million	78,881 Added 136.77%	136,555 $12.4 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $57,400 - $63,535	-368 Reduced 0.63%	57,674 $9.33 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $1.01 Million - $1.22 Million	7,651 Added 15.18%	58,042 $9.24 Million
Q4 2022 Feb 15, 2023	BUY	$102.55 - $135.33 $2.22 Million - $2.93 Million	21,685 Added 75.54%	50,391 $6.82 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $548,241 - $672,815	5,754 Added 25.07%	28,706 $2.86 Million
Q2 2022 Aug 04, 2022	BUY	$103.24 - $121.81 $978,508 - $1.15 Million	9,478 Added 70.34%	22,952 $2.56 Million
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $22,437 - $27,122	-241 Reduced 1.76%	13,474 $1.5 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $458,402 - $559,759	-4,781 Reduced 25.85%	13,715 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $104,174 - $131,569	1,234 Added 7.15%	18,496 $1.78 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $61,773 - $77,385	-913 Reduced 5.02%	17,262 $1.45 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $22,532 - $25,475	336 Added 1.88%	18,175 $1.23 Million
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $28,431 - $32,841	-445 Reduced 2.43%	17,839 $1.25 Million
Q3 2020 Oct 30, 2020	SELL	$63.69 - $70.22 $186,293 - $205,393	-2,925 Reduced 13.79%	18,284 $1.27 Million
Q2 2020 Aug 06, 2020	BUY	$58.54 - $67.94 $250,551 - $290,783	4,280 Added 25.28%	21,209 $1.39 Million
Q1 2020 Apr 29, 2020	BUY	$49.46 - $64.78 $296 - $388	6 Added 0.04%	16,929 $1.02 Million
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $2,243 - $2,621	-45 Reduced 0.27%	16,923 $979,000
Q3 2019 Oct 30, 2019	BUY	$47.54 - $53.43 $11,599 - $13,036	244 Added 1.46%	16,968 $877,000
Q2 2019 Jul 25, 2019	BUY	$46.79 - $52.47 $4,725 - $5,299	101 Added 0.61%	16,724 $853,000
Q1 2019 Apr 30, 2019	BUY	$46.36 - $52.63 $22,345 - $25,367	482 Added 2.99%	16,623 $869,000
Q4 2018 Jan 15, 2019	BUY	$41.54 - $47.25 $6,978 - $7,938	168 Added 1.05%	16,141 $743,000
Q3 2018 Oct 23, 2018	SELL	$46.76 - $51.24 $4,956 - $5,431	-106 Reduced 0.66%	15,973 $753,000
Q2 2018 Jul 20, 2018	SELL	$44.29 - $50.42 $11,293 - $12,857	-255 Reduced 1.56%	16,079 $742,000
Q1 2018 Apr 20, 2018	BUY	$48.49 - $58.14 $3,927 - $4,709	81 Added 0.5%	16,334 $804,000
Q4 2017 Jan 19, 2018	BUY	$47.53 - $53.73 $11,074 - $12,519	233 Added 1.45%	16,253 $872,000
Q3 2017 Nov 22, 2017	SELL	$41.15 - $49.22 $20,328 - $24,314	-494 Reduced 2.99%	16,020 $771,000
Q2 2017 Nov 22, 2017	BUY	N/A	87 Added 0.53%	16,514 $708,000
Q1 2017 Nov 22, 2017	BUY	N/A	15,217 Added 1257.6%	16,427 $563,000
Q4 2016 Nov 22, 2017	BUY	N/A	1,210	1,210 $43,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Novo Nordisk A S Transaction History